4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000062
Chief Executive Officer sold 1,729 shares at $69.69 ($120,494)
From the SEC's structured data for this filing
Trades in this filing
Klein Lawrence Otto · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-15 | Sale : show line 1 in the form | −1,729 | $69.69 | $120,494 | 925,580 | D |
| Open-market sales · 1,729 sh · avg $69.69 · $120,494 | ||||||
Loading xslF345X06/form4.xml…